Vanguard Personalized Indexing Management’s Tenaya Therapeutics TNYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.8K Sell
34,871
-19,068
-35% -$14.5K ﹤0.01% 2193
2026
Q1
$37.3K Buy
53,939
+7,964
+17% +$5.88K ﹤0.01% 2081
2025
Q4
$32.7K Buy
45,975
+149
+0.3% +$203 ﹤0.01% 1918
2025
Q3
$74.2K Sell
45,826
-343
-0.7% -$345 ﹤0.01% 1858
2025
Q2
$28.2K Buy
46,169
+11,656
+34% +$5.93K ﹤0.01% 1884
2025
Q1
$19.7K Buy
34,513
+23,248
+206% +$22.9K ﹤0.01% 1774
2024
Q4
$16.1K Buy
+11,265
New +$25.3K ﹤0.01% 1782

Other funds holding TNYA

Vanguard Personalized Indexing Management's TNYA Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Tenaya Therapeutics (TNYA) stake by 35% in Q2 2026, selling an estimated $14.5K and leaving 34,871 shares worth $25.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2193.

Vanguard Personalized Indexing Management first reported a position in TNYA in Q4 2024 and has held it in 7 quarters since. The position peaked at $74.2K in Q3 2025. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Vanguard Personalized Indexing Management held 34,871 shares of Tenaya Therapeutics worth $25.8K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 19,068 Tenaya Therapeutics shares in Q2 2026, an estimated $14.5K.
  • Tenaya Therapeutics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2193 holding.
  • Vanguard Personalized Indexing Management first reported a position in Tenaya Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Vanguard Personalized Indexing Management's Tenaya Therapeutics position peaked at $74.2K in Q3 2025.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.